A new agonist of the erythropoietin receptor, Epobis, induces neurite outgrowth and promotes neuronal survival

Journal of Neurochemistry

Volumn 121, Issue 6, 2012, Pages 915-923

  Pankratova, Stanislava ^a   Gu, Bing ^a   Kiryushko, Darya ^a   Korshunova, Irina ^a   Køhler, Lene B ^a   Rathje, Mette ^a   Bock, Elisabeth ^a   Berezin, Vladimir ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EPOBIS PEPTIDE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HORMONE RECEPTOR STIMULATING AGENT; KAINIC ACID; POTASSIUM CHLORIDE; RECOMBINANT ERYTHROPOIETIN; STAT5 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CELL SURVIVAL; CEREBELLUM; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HIPPOCAMPUS; IN VITRO STUDY; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NERVE FIBER GROWTH; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; BLOTTING, WESTERN; CELL SURVIVAL; ERYTHROPOIETIN; GENE KNOCKDOWN TECHNIQUES; HUMANS; MODELS, MOLECULAR; NEURITES; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; RATS; RATS, WISTAR; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; TRANSFECTION;

EID: 84862005295     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07751.x     Document Type: Article

References (44)

1. Boissel J. P., Lee W. R., Presnell S. R., Cohen F. E. and Bunn H. F. (1993) Erythropoietin structure-function relationships. Mutant proteins that test a model of tertiary structure. J. Biol. Chem. 268, 15983-15993. (Pubitemid 23222105)
2. Brines M. and Cerami A. (2005) Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci. 6, 484-494. (Pubitemid 40769173)
3. Brines M. and Cerami A. (2008) Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J. Intern. Med. 264, 405-432.
4. Brines M., Grasso G., Fiordaliso F. et al. (2004) Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl Acad. Sci. USA 101, 14907-14912. (Pubitemid 39410773)
5. Brines M., Patel N. S., Villa P. et al. (2008) Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc. Natl Acad. Sci. USA 105, 10925-10930.
6. Byts N., Samoylenko A., Fasshauer T., Ivanisevic M., Hennighausen L., Ehrenreich H. and Siren A. L. (2008) Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death Differ. 15, 783-792. (Pubitemid 351405083)
7. Campana W. M., Misasi R. and O'Brien J. S. (1998) Identification of a neurotrophic sequence in erythropoietin. Int. J. Mol. Med. 1, 235-241.
8. Cheetham J. C., Smith D. M., Aoki K. H., Stevenson J. L., Hoeffel T. J., Syed R. S., Egrie J. and Harvey T. S. (1998) NMR structure of human erythropoietin and a comparison with its receptor bound conformation. Nat. Struct. Biol. 5, 861-866. (Pubitemid 28467406)
9. Elliott S., Lorenzini T., Chang D., Barzilay J. and Delorme E. (1997) Mapping of the active site of recombinant human erythropoietin. Blood 89, 493-502. (Pubitemid 27051684)
10. Erbayraktar S., Grasso G., Sfacteria A. et al. (2003) Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc. Natl Acad. Sci. USA 100, 6741-6746. (Pubitemid 36666650)
11. Giulian D. and Baker T. J. (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6, 2163-2178. (Pubitemid 16043659)
12. Hansen R. K., Christensen C., Korshunova I. et al. (2007) Identification of NCAM-binding peptides promoting neurite outgrowth via a heterotrimeric G-protein-coupled pathway. J. Neurochem. 103, 1396-1407. (Pubitemid 47631829)
13. Kawakami M., Sekiguchi M., Sato K., Kozaki S. and Takahashi M. (2001) Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J. Biol. Chem. 276, 39469-39475.
14. Kirkeby A., Torup L., Bochsen L., Kjalke M., Abel K., Theilgaard-Monch K., Johansson P. I., Bjorn S. E., Gerwien J. and Leist M. (2008) High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO). Thromb. Haemost. 99, 720-728. (Pubitemid 351694228)
15. Kiryushko D., Novitskaya V., Soroka V., Klingelhofer J., Lukanidin E., Berezin V. and Bock E. (2006) Molecular mechanisms of Ca(2+) signaling in neurons induced by the S100A4 protein. Mol. Cell Biol. 26, 3625-3638.
16. Konishi Y., Chui D. H., Hirose H., Kunishita T. and Tabira T. (1993) Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res. 609, 29-35. (Pubitemid 23136796)
17. Leist M., Ghezzi P., Grasso G. et al. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305, 239-242. (Pubitemid 38886736)
18. Liu Z., Stoll V. S., Devries P. J. et al. (2007) A potent erythropoietin-mimicking human antibody interacts through a novel binding site. Blood 110, 2408-2413. (Pubitemid 47523161)
19. Livnah O., Stura E. A., Johnson D. L., Middleton S. A., Mulcahy L. S., Wrighton N. C., Dower W. J., Jolliffe L. K. and Wilson I. A. (1996) Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science 273, 464-471. (Pubitemid 26286442)
20. Livnah O., Johnson D. L., Stura E. A. et al. (1998) An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat. Struct. Biol. 5, 993-1004. (Pubitemid 28506633)
21. Maiese K., Li F. and Chong Z. Z. (2005) New avenues of exploration for erythropoietin. JAMA 293, 90-95. (Pubitemid 40066704)
22. Maiese K., Chong Z. Z., Li F. and Shang Y. C. (2008) Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies. Prog. Neurobiol. 85, 194-213.
23. McConnell S. J., Dinh T., Le M. H., Brown S. J., Becherer K., Blumeyer K., Kautzer C., Axelrod F. and Spinella D. G. (1998) Isolation of erythropoietin receptor agonist peptides using evolved phage libraries. Biol. Chem. 379, 1279-1286. (Pubitemid 28484446)
24. Middleton S. A., Barbone F. P., Johnson D. L. et al. (1999) Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide. J. Biol. Chem. 274, 14163-14169.
25. Morishita E., Masuda S., Nagao M., Yasuda Y. and Sasaki R. (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76, 105-116. (Pubitemid 26407940)
26. Nadam J., Navarro F., Sanchez P., Moulin C., Georges B., Laglaine A., Pequignot J. M., Morales A., Ryvlin P. and Bezin L. (2007) Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol. Dis. 25, 412-426. (Pubitemid 46138046)
27. Nagao M., Wen T. C., Okamoto M., Irie K., Takaku T. and Sakanaka M. (2005) In vivo neuroprotective activity of epopeptide AB against ischemic damage. Cytotechnology 47, 139-144. (Pubitemid 41784675)
28. Pankratova S., Kiryushko D., Sonn K. et al. (2010) Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor. Brain 133, 2281-2294.
29. Qureshi S. A., Kim R. M., Konteatis Z. et al. (1999) Mimicry of erythropoietin by a nonpeptide molecule. Proc. Natl Acad. Sci. USA 96, 12156-12161. (Pubitemid 29502874)
30. Ransome M. I. and Turnley A. M. (2008) Erythropoietin promotes axonal growth in a model of neuronal polarization. Mol. Cell. Neurosci. 38, 537-547.
31. Remy I., Wilson I. A. and Michnick S. W. (1999) Erythropoietin receptor activation by a ligand-induced conformation change. Science 283, 990-993.
32. Ronn L. C., Ralets I., Hartz B. P., Bech M., Berezin A., Berezin V., Moller A. and Bock E. (2000) A simple procedure for quantification of neurite outgrowth based on stereological principles. J. Neurosci. Methods 100, 25-32.
33. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., Priller J., Dirnagl U. and Meisel A. (2002) Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22, 10291-10301. (Pubitemid 35416867)
34. Sanchez P. E., Navarro F. P., Fares R. P. et al. (2009) Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span. J. Comp Neurol. 514, 403-414.
35. Schousboe A., Meier E., Drejer J. and Hertz L. (1989) Preparation of Primary Cultures of Mouse (Rat) Cerebellar Granule Cells. A Dissection and Tissue Culture Manual of the Nervous System. Alan R. Liss, New York.
36. Siren A. L., Fratelli M., Brines M. et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl Acad. Sci. USA 98, 4044-4049. (Pubitemid 32249895)
37. Siren A. L., Fasshauer T., Bartels C. and Ehrenreich H. (2009) Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 6, 108-127.
38. Syed R. S., Reid S. W., Li C. et al. (1998) Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395, 511-516. (Pubitemid 28462447)
39. Torup L. (2007) Neuroprotection with or without erythropoiesis; sometimes less is more. Br. J. Pharmacol. 151, 1141-1142.
40. Um M., Gross A. W. and Lodish H. F. (2007) A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell. Signal. 19, 634-645. (Pubitemid 46107815)
41. Villa P., Bigini P., Mennini T. et al. (2003) Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 198, 971-975. (Pubitemid 37152934)
42. Viviani B., Bartesaghi S., Corsini E., Villa P., Ghezzi P., Garau A., Galli C. L. and Marinovich M. (2005) Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J. Neurochem. 93, 412-421. (Pubitemid 40547498)
43. Wilson I. A. and Jolliffe L. K. (1999) The structure, organization, activation and plasticity of the erythropoietin receptor. Curr. Opin. Struct. Biol. 9, 696-704.
44. Wrighton N. C., Farrell F. X., Chang R., Kashyap A. K., Barbone F. P., Mulcahy L. S., Johnson D. L., Barrett R. W., Jolliffe L. K. and Dower W. J. (1996) Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273, 458-464.